Autosomal Reciprocal Translocations 135 RISK AT THE TIME OF PREIMPLANTATION GENETIC TESTING PGT for a reciprocal translocation has been available for much of this century. Initially, it was the day-3 cleavage-stage embryo at IVF that was analyzed, but latterly it has been the day-5 blastocyst that is chosen (Chapter 23). In terms of the relative detection rates at these two timeframes, there is a small but definite increase in the normal/balanced detection rate, from 25% to 28% (Tian et al. 2022); this likely reflects a lethality of embryos with a substantial monosomic load during the day 4 to day 5–6 period. PGT requires a very different viewpoint, since in utero (in other words, post-implantation) lethality has not had the chance to operate; hence a wide range of imbalances may be seen, the great majority of which could never survive to term, and indeed, many would fail even before implantation. The numerator/denominator of the risk figure becomes the fractions of euploid and aneuploid embryos out of all created embryos. The overall figure of about one-quarter to one-third, for the fraction of day-5 embryos that are euploid, is consistently seen across a number of studies in which large numbers (thousands) of blastocysts have been analyzed (Xie et al. 2022; Oğur et al. 2023; Zhou et al.2024). A typical range of findings is shown (Table 5–6) in the smaller study of Shetty et al. (2022). In the series of Xie et al., in which over 2,000 rcp carrier couples were studied—all of whom had presented with histories of infertility, recurrent spontaneous abortion, or having had a pregnancy with a chromosomal abnormality—the segregation ratios were as follows: alternate, 46%; adjacent-1, 31%; adjacent-2, 12%; and 3:1, 30%. A proportion of these embryos may have other aneuploidies unrelated to the translocation, and more so in the case of an older mother. In the series of Zhou et al. (2024), one-fifth of blastocysts had an abnormality unrelated to the translocation. The subtleties of the range of potential imbalances here may be, to some counselees, a little beside the point: the aim is, naturally, to select a normal/balanced embryo, and whatever the abnormal ones are, they can be disregarded. What really matters, of course, is the take-home baby rate (Lledó et al. 2010). Overall, the proportion of successful pregnancies per embryo transfer, after PGT, is around one-half. In the series of Oğur et al. (2023), that figure was 43% for mothers under age 35, and 58% for those over that age; interestingly, the respective miscarriage rates, at 12% and 5%, were actually less than the general population risk.12 Xie et al. (2022) reported an overall delivery rate, per embryo transfer, of 50%. A similar livebirth figure (56%) comes from Zhou et al. (2024) in couples who had a single embryo transfer. If the chances of an embryo at PGT being normal is one-third, and the odds for a successful transfer one-half, only one in six fertilized ova will, on average, result in a baby. Tong et al. (2022b) propose that four or more embryos would need to be created in order to improve the odds of having at least one euploid embryo. The absence of any effect on the outcome due to parental gender is confirmed in Tan et al. (2025). Of the euploid embryos, essentially one-half are non-carriers of the translocation (Zhou et al. 2024). It is possible to distinguish between a carrier and a normal embryo via haplotype analysis, using genotype data generated from SNP arrays (Treff et al. 2016; Xu et al. 2017), whole genome sequencing (Zhai et al. 2022), or long-read nanopore sequencing (Madjunkova et al. 2020). While this may be an attractive option to parents who will be only too aware of the complicated reproductive implications of 12 The numbers in each age group were not large, 52 cf. 22, and so the apparently better outcomes for older mothers should not be over-interpreted.
Table 5–6. Chromosome Segregations in 65 Blastocysts of 8 Female and 8 Male Reciprocal Translocation Heterozygotes, and the Outcomes TRANSLOCATION BLASTOCYSTS BIOPSIED CHROMOSOMAL DIAGNOSES EMBRYOS TRANSFERRED OUTCOME POST TRANSFER Normal (n) Unbalanced 46,XX, t(1;6)(p36.1;q13) 4 0 (−6), (+1,−6), (+6), M 0 n/a 46,XY,t(2;17)(q31;p13) 3 1 (−2), (+2) 1 Delivery 46,XY,t(4;18)(p12;q11.2) 3 1 (−4,+8), M 1 Delivery 46,XY,t(4;21)(q25;q22) 2 0 (+4, −21), (−4,+21) 0 n/a 46,XX,t(5;8)(q31;p22) 4 2 7, S 2 Delivery 46,XX,t(5;9)(q22;p22) 7 2 (+5,−9) ×3, (−5,+9) ×2 2 Delivery 46,XX,t(6;7)(q25;q22) 5 2 (−6,+7), (−7), (−6,+7,−16) 1 Failed transfer 46,XY,t(6;11)(p21;q23) 2 1 (−6,+11) 1 Delivery 46,XX,t(7;13)(p13;q22) 6 2 (+7,−13), (+7,−13,−11), (−7,+13), M 1 Failed transfer 46,XY,t(7;17)(p22;p11) 4 2 (−17), M 1 Failed transfer 46,XX,t(8;12)(p11.2;q24.3) 5 2 (−8), (+8,−12), M 2 Delivery 46,XY,t(8;15)(q13;q24) 4 1 (+8,−15), +3, +6 1 Delivery 46,XY,t(9;22)(q34;q11) 4 3 +6 2 Delivery 46,XX,t(10;14)(p13;q24) 3 2 (−14,−22) 1 Miscarriage 46,XX,t(11;22)(q23;q11.2) 6 1 (+11,−22) ×2, (+11), (−11+22), S 1 Failed transfer 46,XY,t(14;21)(q22;q22.1) 3 0 (+3,+6), (+14, −21), (−14, +21) 0 n/a TOTALS 65 22 43 8 deliveries Notes: The + and − refer either to translocation segments, or to the whole chromosome. Thus, +2 = dup(2) or trisomy 2, and −6 = del(6) or monosomy 6. M = multiple aneuploidies; S = sex chromosome abnormality. n/a = not applicable. As well as an overall fraction of 46% of embryos imbalanced due to malsegregation of the translocation chromosomes, 17% had an unrelated sporadic aneuploidy: note that some of the imbalances listed above involve a chromosome not involved in the translocation. “Normal” includes the balanced carrier state. In half of couples, a successful pregnancy was achieved. Source: S Shetty et al., Preimplantation genetic testing for couples with balanced chromosomal rearrangements, J Reprod Infertil 23:213–223, 2022.